Receiving a benralizumab injection during an acute asthma or COPD exacerbation with a blood eosinophil count of at least 300 cells/µL led to fewertreatment failures, according to results ...

Age, asthma diagnosis, number of exacerbations, and number of benralizumab treatment records within specified periods were used to identify a total of 1795 participants for inclusion in the study.

Bafadhel's team randomly assigned more than 150 asthma and COPD patients being treated in emergency departments of English ...

Treatment with benralizumab in adults with severe, uncontrolled asthma was well tolerated for up to 5 years, with a long-term safety profile consistent with previous phase 3 trials.The data come ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an injection is more effective than the current care of steroid tablets and ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks, calling it the first major advance for this aspect of the disease in 50 ...

Benralizumab, a monoclonal antibody, is already used for the long-term management of eosinophilic asthma, with studies still evaluating the effect of long-term management in eosinophilic COPD.

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial, The Lancet Respiratory Medicine.

For the clinical trial, researchers divided asthma or COPD patients into one of three groups – one receiving benralizumab during a flare-up, another taking prednisolone tablets, and a third ...

The drug, which is called benralizumab, is the first new treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years. A trial has shown that using the drug can cut ...

A new treatment for asthma attacks is being described as “game-changing” by the London scientists who created it. The drug, which is called benralizumab, is the first new treatment for asthma ...